ATP-sensitive potassium (K~ATP~) channels were first identified in cardiac cell, and their physiological functions, such as hypoxic and ischemic conditions, are well characterized, even in smooth muscle and pancreatic cells \[[@r3],[@r4],[@r5], [@r9], [@r10], [@r20]\]. Cellular metabolism is tightly linked to regulation of K~ATP~ channel activity, as the channels open in response to lower ATP levels and close in response to higher ATP levels. KCOs, such as pinacidil and diazoxide \[[@r3], [@r4], [@r16], [@r22]\], open K~ATP~ channels, and glibenclamide blocks opening of the channels \[[@r3], [@r4], [@r16], [@r24]\]. Basically, activated K~ATP~ channels hyperpolarize, which opposes muscle excitability and reduces calcium influx via voltage-dependent L-type Ca^2+^ channels (VDCC~L~) \[[@r3]\]. At molecular level, the K~ATP~ channel is composed of subunits from a combination of inwardly rectifying K^+^ channels (Kir6.1 or Kir 6.2) and sulfonylurea receptors (SUR1, 2A and 2B) \[[@r2], [@r3]\].

Antociban and β-adrenoceptor agonists have been used to reduce preterm myometrial contractions, but are unsatisfactory \[[@r5], [@r6]\]. Premature delivery remains a major risk factor for perinatal mortality \[[@r21], [@r25]\]. Myometrial contractions are quiescent during pregnancy, but are enhanced dramatically for labor at term \[[@r18]\]. The regulation of myometrial contractions is modulated by many endogenous factors, such as polypeptide hormones and neurotransmitters \[[@r26]\].

In addition, changes of ion channel activities in non-pregnant and pregnant myometra are also important for myometrial contractility \[[@r19]\]. Basically, activation of K^+^ channels opposes muscle excitability and relaxes the myometrium by regulating the resting membrane potential. Several types and/or different activities of K^+^ channels, such as Ca^2+^-activated K^+^ (K~Ca~) channels and voltage-dependent K^+^ (K~V~) channels, are involved in the regulation of myometrial contractility in non-pregnant and pregnant myometria \[[@r10], [@r13],[@r14],[@r15], [@r23]\]. Recently, we also reported functional upregulation of TASK-2 channels in pregnant than that in non-pregnant mice \[[@r10]\]. Interestingly, K~ATP~ channels is also key contributors to labor at term \[[@r7]\]. However, the existence subtypes and role of K~ATP~ channels in myometrium is still not well defined. Therefore, we characterized the molecular isoforms and physiological functions of K~ATP~ channels in murine myometrium in this study.

MATERIALS AND METHODS {#s1}
=====================

*Tissue preparation for isometric contraction*: All experiments were performed in accordance with the guidelines for animal care and use approved by Chungbuk National University and The Physiological Society of Shanghai Jiaotong University. Female non-pregnant ICR (age, 10--12 weeks) mice were anesthetized with fluoromethyl 2,2,2-trifluoro-1 (trifluoromethyl) ethyl ether (Sevoflurane; Maruishi Pharma., Osaka, Japan) and killed by cervical dislocation \[[@r10]\]. The uteri were cut open from the neck to the end of the uterine horns, rinsed in Krebs-Ringer bicarbonate (KRB) solution and pinned on a Sylgard plate \[[@r10]\]. Longitudinal muscle strips (1 × 5 mm) were mounted on vertical chambers in an isometric contractile measuring system. One end of the tissue was tied to a fixed holder, and the other side was linked to a force transducer (Harvard Instruments, Holliston, MA, U.S.A.). The PowerLab-Data Acquisition System and a personal computer running Charter v5.5 software (ADinstruments, Colorado Springs, CO, U.S.A.) were used. Each strip was stretched passively to resting tension for 1--2 hr after a 1.5 hr equilibration \[[@r10]\]. Contractile responses of the strip to high K^+^ (50 mM) were repeated two times.

*Solution and drugs*: KRB solution (CO~2~/bicarbonate-buffered Tyrode) contained (in mM): NaCl 122, KCl 4.7, MgCl~2~ 1, CaCl~2~ 2, NaHCO~3~ 15, KH~2~PO~4~ 0.93 and glucose 11 (pH 7.3--7.4, bubbled with 5% CO~2~/95% O~2~). Equimolar concentration of Na^+^ was replaced by K^+^ to make high K^+^ (50 mM) solution. The external solution was changed by solutions which had previously been incubated (bubbled with 5% CO~2~/95% O~2~, 36°C) in water bath before the application. Pretreatment of various blockers was applied for 12--15 min before the application of KCOs. All drugs used in this study were purchased from Sigma (St. Louis, MO, U.S.A.).

*Western blot*: Tissues were fresh-frozen in liquid nitrogen and were homogenized in homogenation buffer containing 0.01% (v/v) protease inhibitor cocktail. Tissue homogenates were then centrifuged for 10 min, and proteins were measured by a Bradford protein assay using BSA as the standard. Equal amounts (20--40 *µ*g) of soluble proteins were separated using 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS--PAGE) at 100V for 90 min and transferred to a PVDF membrane. The PVDF membranes were blocked with 5% skim-milk in TBS buffer solution, followed by incubation with Kir 6.1, Kir 6.2, SUR1, SUR2A and SUR2B (Santa Cruz (Dallas, TX, U.S.A.); Millipore (Darmstadt, Germany); and Streess Marq (Victoria, Canada); 1:500--1:200) antibodies. The membranes were incubated with secondary antibody (1:5,000) diluted in TBS for 1 hr, followed by 3 washes. β-actin (Abfrontier, 1:2,000) and Goat anti-rabbit IgG secondary antibody (Santa Cruz, 1:5,000) were also used.

*Statistics*: Data were expressed as means ± standard errors of the mean (means ± SEM). The ANOVA and Student's *t*-test were used to measure the statistical significance. *P*-values less than 0.05 were regarded as statistically significant.

RESULTS {#s2}
=======

*Inhibition of isometric contractions in murine myometrium by pinacidil*: Spontaneous isometric contractions of 1.9 ± 0.4 g and 3 ± 2.1 cycles/min were recorded (n=60) ([Figs. 1A, 2A, 2B and 4A](#fig_001){ref-type="fig"}Fig. 1.Inhibition of murine myometrial contractions by pinacidil. (A) Pinacidil (5 *µ*M) inhibited spontaneous contractions of murine longitudinal myometrium in a glibenclamide-sensitive manner. (B) Oxytocin (OXT, 10 nM) produced tri-phasic contractions, such as initial contractions, followed by tonic contractions overlapped with phasic contractions. Pinacidil inhibited OXT-induced phasic contractions to 12% of the control. Data are summarized in (C) and (D).). High K^+^ produced 0.4 ± 0.07 g contractions (n=60; data not shown). Pinacidil (5 *µ*M), which opens K~ATP~ channels (KCOs), inhibited spontaneous myometrial contractions in a glibenclamide-sensitive manner ([Fig. 1A](#fig_001){ref-type="fig"}). Pinacidil (5, 10 and 20 *µ*M) inhibited phasic contractions of murine longitudinal myometrium to 14 ± 12.1%, 8 ± 8.3% and 0% of the control (n=8, 6 and 4, respectively; *P*\<0.05; [Fig. 1C](#fig_001){ref-type="fig"}). Glibenclamide, which blocks K~ATP~ channels, reversed the inhibition of spontaneous isometric contractions by pinacidil (5 *µ*M) to 63 ± 12% of the control (n=6; *P*\<0.05; [Fig. 1C](#fig_001){ref-type="fig"}). Oxytocin (OXT, 10 nM) produced tri-phasic contractions that included initial contractions, followed by tonic contractions overlapped with phasic contractions ([Fig. 1B](#fig_001){ref-type="fig"}). The phasic contractions produced by OXT (10 nM) were inhibited by pinacidil (20, 50 and 100 *µ*M) to 26 ± 25.8%, 19 ± 12.5% and 18 ± 11.9% of the control (n=4, 7 and 5, respectively; *P*\<0.05; [Fig. 1D](#fig_001){ref-type="fig"}). Glibenclamide reversed the inhibition of spontaneous isometric contractions by pinacidil (50 *µ*M) to 86 ± 26.5% of the control (n=5; *P*\<0.05; [Fig. 1D](#fig_001){ref-type="fig"}).

*Inhibition of isometric contractions in murine myometrium by cromakalim*: Cromakalim inhibited spontaneous contractions completely in a glibenclamide-sensitive manner. Cromakalim (5 *µ*M) inhibited spontaneous contractions, which were recovered by glibenclamide ([Fig. 2A and 2C](#fig_002){ref-type="fig"}Fig. 2.Inhibition of murine myometrial contractions by cromakalim. (A) Cromakalim (5 *µ*M) completely inhibited spontaneous contractions of murine myometrium in a glibenclamide-sensitive manner. (B) Cromakalim (20 *µ*M) completely inhibited OXT (10 nM)-induced phasic contractions in a glibenclamide-sensitive manner. Data are summarized in (C) and (D).). Cromakalim (1, 5 and 10 *µ*M) inhibited phasic contractions to 34 ± 21.1%, 20.1 ± 20.0% and 0% of the control (n=5, respectively; *P*\<0.05; [Fig. 2C](#fig_002){ref-type="fig"}). Glibenclamide reversed the inhibition of spontaneous isometric contractions caused by cromakalim (5 *µ*M) to 84 ± 1.5% of the control (n=5; *P*\<0.05; [Fig. 2C](#fig_002){ref-type="fig"}). Cromakalim (20 and 100 *µ*M) also inhibited OXT (10 nM)-induced phasic contractions to 34 ± 21.4% and 14 ± 12.6% of the control (n=6 and 4, respectively; *P*\<0.05; [Fig. 2B](#fig_002){ref-type="fig"} and 2D). Glibenclamide reversed the inhibition of spontaneous isometric contractions by cromakalim (100 *µ*M) to 79 ± 3.5% of the control (n=4; *P*\<0.05;[Fig. 2D](#fig_002){ref-type="fig"}). As shown in [Fig. 2B](#fig_002){ref-type="fig"}, tonic contraction by OXT was also suppressed by cromakalim in a glibenclamide-sensitive manner.

*Inhibition of isometric contractions in murine myometrium by nicorandil*: Nicorandil (20--100 *µ*M) inhibited spontaneous myometrial contractions in a glibenclamide-sensitive manner ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Inhibition of murine myometrial contractions by nicorandil. (A) Nicorandil inhibited spontaneous contraction of murine longitudinal myometrium in a glibenclamide-sensitive manner. Nicorandil (100--300 *µ*M) inhibited spontaneous contraction completely. (B) Oxytocin (OXT, 10 nM)-induced phasic contractions were inhibited to 40% of the control at Nicorandil (500 *µ*M). Data are summarized in (C) and (D).). Nicorandil (20, 50, 100 and 300 *µ*M) inhibited spontaneous myometrial contractions to 90 ± 2.0%, 63 ± 10.8%, 27 ± 10.2% and 0% of the control (n=6, 12, 12 and 1, respectively; *P*\<0.05; [Fig. 3C](#fig_003){ref-type="fig"}). OXT (10 nM)-induced phasic contractions were also inhibited by nicorandil (100--500 *µ*M) in a glibenclamide-sensitive manner ([Fig. 3B](#fig_003){ref-type="fig"}). OXT (10 nM)-induced phasic contractions were inhibited by nicorandil (100 and 500 *µ*M) to 65 ± 15.7% and 40 ± 19.7% of the control (n=11 and 8, respectively; *P*\<0.05; [Fig. 3D](#fig_003){ref-type="fig"}). Glibenclamide reversed the inhibition of spontaneous and OXT-induced phasic contractions caused by nicorandil (100 *µ*M and 500 *µ*M) to 71 ± 8.6% and 113 ± 2.9% of the control (n=10 and 5, respectively; *P*\<0.05; [Fig. 3C](#fig_003){ref-type="fig"} and 3D).

*Inhibition of prostaglandin F~2α~ (PGF~2α~)-induced phasic contractions in murine myometrium by KCOs*: PGF~2α~ produced tri-phasic contractions, such as initial contractions, followed by tonic contractions overlapped with phasic contractions in murine uterine smooth muscle ([Fig. 4A--4D](#fig_004){ref-type="fig"}Fig. 4.Prostaglandin F~2α~ (PGF~2α~)-induced contractions were inhibited by K^+^ channel opening agents (KCOs). (A--D) PGF~2α~ produced tri-phasic contractions, such as initial contractions, followed by tonic contractions overlapped with phasic contractions. PGF~2α~-induced phasic contractions were inhibited by pinacidil, diazoxide, cromakalim and nicorandil.). PGF~2α~-induced phasic contractions were inhibited completely by pinacidil (10 *µ*M), diazoxide (100 *µ*M), cromakalim (10 *µ*M) and nicorandil in a glibenclamide-sensitive manner (n=3, 3, 3 and 2, respectively; *P*\<0.05; [Fig. 4A](#fig_004){ref-type="fig"}--4D). In addition, all KCOs completely inhibited acetylcholine (ACh)-induced contractions in a glibenclamide-sensitive manner too (data not shown; *see discussion*).

*Identity of the K~ATP~ channel subunits in murine myometrium*: The identity of the K~ATP~ channel in murine myometrium was studied. SUR1, SUR2A and Kir6.1 were not detected by Western blot. However, proteins compatible with SUR2B (58K) and Kir6.2 (55K), which were composed of K~ATP~ channels, were detected in murine myometrium ([Fig. 5A and 5B](#fig_005){ref-type="fig"}Fig. 5.Identification of K~ATP~ channel subunits in murine longitudinal myometrium. The SUR and Kir subtypes were studied by Western blot. SUR1, SUR2A and Kir6.1 were not detected in murine myometrium. (A, B) However, the SUR2B and Kir6.2 subtypes were detected in murine myometrium by Western blot.). The density of each SUR2B/β-actin and Kir6.2/β-actin was 383 ± 112.4 and 236 ± 58.8 (n=5 and 7, respectively).

DISCUSSION {#s3}
==========

This is the first report that K~ATP~ channels composed or SUR2B and Kir6.2 produced relaxation of various contractions by diverse KCOs of murine myometrium.

Regulation of smooth muscle function via K~ATP~ channels is dependent on these types of Kir and/or SUR isoforms \[[@r3], [@r22]\]. K~ATP~ channels are octomeric proteins formed with inwardly rectifying potassium (Kir) channel subunits along with SUR receptor subunits, and there are several types of K~ATP~ channel combinations \[[@r2], [@r3]\]. In structure, Kir is a pore forming structure, and SUR provides binding sites for ATP and KCOs \[[@r2], [@r3]\]. The combination of Kir6.1/SUR2B (and/or Kir6.2/SUR2B) in vascular smooth muscle \[[@r3]\] and Kir6.2/SUR2B in guinea-pig stomach was identified \[[@r22]\]. K~ATP~ channels in atrial and ventricular myocytes are composed differently, as atrial and ventricular myocytes have the same Kir 6.2 subunit but different SUR subtypes called SUR1 and SUR2A, respectively \[[@r3]\]. The physiological functions of K~ATP~ channels are diverse in various tissues, including regulation of resting membrane potential modulation of calcium influx, and regulating the force and frequency of gastrointestinal tract contractions \[[@r3], [@r22]\]. Therefore, their function cannot be determined without isolating the isoforms from each tissue.

In myometrium, Kir6.1, Ki6.2, SUR1 and SUR2B isoforms have been identified in human myometrium \[[@r7]\]. Recently, expression of SUR2A subtype was also reported \[[@r9]\]. However, isoforms of Kir6.1 and SUR2B only have been identified as functional K~ATP~ channel in rat and human \[[@r9], [@r20]\]. In our study, as shown in results, we detected Kir6.2 and SUR2B subtypes in murine myometrium by Western blot ([Fig. 5](#fig_005){ref-type="fig"}). Other subtypes were not detected in Western blot. At this moment, unfortunately, we cannot explain the different expression of K~ATP~ channels in each myometrium. Functionally, pinacidil and diazoxide are representative activators of K~ATP~ channels in mammals by relaxing human uterine arterial and human pregnant uterine smooth muscle \[[@r17], [@r20]\]. As shown in [Figs. 1](#fig_001){ref-type="fig"} and 4A, pinacidil relaxed murine longitudinal uterine muscle. Although data not shown, diazoxide (100, 200 and 300 *µ*M) inhibited spontaneous contractions to 63 ± 11.1%, 26 ± 16.3% and 0% of the control (n=9, 5 and 4, respectively; *P*\<0.05) in a glibenclamide-sensitive manner (recovered to 56 ± 7.1% of the control; *P*\<0.05; [Fig. 2C](#fig_002){ref-type="fig"}). Diazoxide (100 and 300 *µ*M) also inhibited OXT-induced phasic contractions to 51 ± 15.0% and 14 ± 13.5% of the control (n=12 and 6, respectively; *P*\<0.05) in a glibenclamide-sensitive manner (recovered to 40 ± 18.4% of the control; *P*\<0.05). It also inhibited PGF~2α~--induced contraction ([Fig. 4B](#fig_004){ref-type="fig"}). In addition, cromakalim and nicorandil suppressed myometrial contractions in a reversible and glibenclamide-sensitive manner ([Figs. 2](#fig_002){ref-type="fig"}, 3, 4C and 4D). Nicorandil and diazoxide have been used to treat ischemic heart disease and hypertension \[[@r11]\]. Nicorandil was as effective as nifedipine for tocolysis during preterm labor in a randomized-controlled study \[[@r11]\]. We found every four KCOs produced glibenclamide-sensitive relaxation of diverse isometric contractions of murine myometrium. Therefore, we believed that combination of Kir6.2 and SUR2B in murine myometrium might be target for every four KCOs and play a crucial role for myometrial relaxation.

K~ATP~ channel expression levels in myometrium may be associated with the stage of pregnancy \[[@r9]\], and K~ATP~ channels in myometrium are down regulated during late pregnancy. It has been suggested that decreased K~ATP~ channel expression at term of pregnancy is responsible for enhanced myometrial contractility at labor. It has also been suggested that upregulation of K~ATP~ channels in parturients \>35-year-of-age might be responsible for the increased rate of birth complication in these women \[[@r9]\]. As strong contractions are produced from several hours to even days during labor, energy metabolism is very complex at this time. In addition, we found that substituting D-mannitol for glucose inhibited the frequency of PGF~2α~-induced contractions from 1.8 ± 0.17 to 0.5 ± 0.14 (n=2; data not shown). Thus, K~ATP~ channels may be one of a target for regulation of myometrial contractions. At molecular level, Kir6.2 is required for protection against myocardiac ischemia/reperfusion (I/R) injury and skeletal muscle weakness \[[@r8], [@r12]\]. In addition, it was also reported that vasodilation by metabolic inhibition, such as oxygen and glucose deprivation (OGD)-mediated inhibition, was attenuated in SUR2 null arteries \[[@r1]\].

Uterine smooth muscle spasms via vascular contracture and/or local contraction of vessels \[[@r17]\] through production of PGF~2α~ might be responsible for dysmenorrhea. Unfortunately, no medications can effectively reduce myometrial spasms factory. We only found the molecular and physiological functions of K~ATP~ channels in this study, and activation of K~ATP~ channels (Kir6.2/SUR2B) in the murine uterus produced reversible relaxation ([Fig. 5](#fig_005){ref-type="fig"}). K~ATP~ channel regulator agents modulate contractility of human and rat smooth muscle. We also observed that KCOs inhibited PGF~2α~-induced contraction in murine myometrium in a reversible- and glibenclamide-sensitive manner ([Fig. 4](#fig_004){ref-type="fig"}). Generally, the regulation of myometrial contraction is modulated by many endogenous factors \[[@r26]\]. Finally, pinacidil (10 *µ*M) inhibited ACh-induced phasic contractions to 17% of the control (n=11; *P*\<0.05) in a glibenclamide-sensitive manner (recovered to 73% of the control; n=8; *P*\<0.05). Diazoxide (100 *µ*M), cromakalim (10 *µ*M) and nicorandil (100 *µ*M) also inhibited it to 43%, 8.6% and 40% of the control in a glibenclamide-sensitive manner (n=6, 5 and 8, respectively; *P*\<0.05; data not shown). Therefore, K~ATP~ channels may be a key factor in menstrual pain, which needs to be studied in the future.
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